Electroacupuncture ameliorates inflammatory pain through CB2 receptor-dependent activation of the AMPK signaling pathway.

Researchers have discovered how electroacupuncture (EA) relieves chronic inflammatory pain by studying mice with inflammation. The study examined whether EA works through a specific biological pathway involving the body's natural pain-relief systems.

Scientists created inflammation in mice using a standard method and then applied electroacupuncture daily for six days at two specific acupuncture points on the leg (ST36 and ST37). They measured pain sensitivity to both touch and heat, and analyzed changes in the inflamed tissue.

The results showed that electroacupuncture significantly reduced pain by activating a cellular energy sensor called AMPK. This activation triggered the release of beta-endorphin, the body's natural painkiller, in the inflamed tissue. The researchers found that EA increased levels of endocannabinoids—natural compounds similar to those found in cannabis—which activated CB2 receptors. These receptors then turned on the AMPK pathway, leading to increased beta-endorphin production.

When researchers blocked either the CB2 receptors (using genetically modified mice) or the AMPK pathway (using an inhibitor drug), electroacupuncture's pain-relieving effects were significantly reduced. This confirmed that both components are essential for EA to work effectively.

For patients suffering from chronic inflammatory pain conditions, this research helps explain why electroacupuncture can be effective. It shows that EA works through multiple natural body systems—the endocannabinoid system, energy metabolism, and endorphin production—to reduce pain and inflammation. This provides scientific support for using electroacupuncture as part of a comprehensive pain management strategy. If you're considering electroacupuncture for inflammatory pain, seek treatment from a licensed acupuncturist trained in electroacupuncture techniques.

This murine study elucidates the mechanism by which electroacupuncture ameliorates inflammatory pain through a CB2R-AMPK-β-endorphin pathway. Using a CFA-induced inflammatory pain model, researchers administered EA at ST36 and ST37 daily for six consecutive days. Mechanical allodynia and thermal hyperalgesia were assessed using Von Frey filaments and hot plate testing.

Key findings demonstrated that EA significantly activated AMPK in inflamed skin tissue, which was attenuated by the AMPK inhibitor Compound C. UPLC-MS/MS analysis revealed elevated endocannabinoids (2-AG and AEA) and upregulated CB2R expression following EA treatment. Immunofluorescence showed AMPK activation and β-endorphin expression in CD68-positive macrophages. Critically, CB2R knockout mice exhibited impaired EA-induced AMPK activation, establishing CB2R as essential for this pathway.

Clinical implications: EA's analgesic effects in inflammatory conditions operate through CB2R-dependent AMPK activation, leading to enhanced β-endorphin expression in peripheral tissues. This mechanism suggests EA may be particularly effective for inflammatory pain conditions and supports targeting ST36/ST37 with electrical stimulation for optimal endocannabinoid-mediated analgesia.